Works matching AU Chowdhury, Reshmi


Results: 13
    1
    2

    SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 423, doi. 10.1007/s11060-019-03126-x
    By:
    • Liu, Fei;
    • Cox, Christopher D.;
    • Chowdhury, Reshmi;
    • Dovek, Laura;
    • Nguyen, Huytram;
    • Li, Tie;
    • Li, Sichen;
    • Ozer, Byram;
    • Chou, Arthur;
    • Nguyen, Nhung;
    • Wei, Bowen;
    • Antonios, Joseph;
    • Soto, Horacio;
    • Kornblum, Harley;
    • Liau, Linda;
    • Prins, Robert;
    • Nghiemphu, P. Leia;
    • Yong, William;
    • Cloughesy, Timothy;
    • Lai, Albert
    Publication type:
    Article
    3
    4

    Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.

    Published in:
    Neuro-Oncology, 2013, v. 15, n. 3, p. 370, doi. 10.1093/neuonc/nos308
    By:
    • Lalezari, Shadi;
    • Chou, Arthur P.;
    • Tran, Anh;
    • Solis, Orestes E.;
    • Khanlou, Negar;
    • Chen, Weidong;
    • Li, Sichen;
    • Carrillo, Jose A.;
    • Chowdhury, Reshmi;
    • Selfridge, Julia;
    • Sanchez, Desiree E.;
    • Wilson, Ryan W.;
    • Zurayk, Mira;
    • Lalezari, Jonathan;
    • Lou, Jerry J.;
    • Ormiston, Laurel;
    • Ancheta, Karen;
    • Hanna, Robert;
    • Miller, Paul;
    • Piccioni, David
    Publication type:
    Article
    5
    6
    7

    Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 3, p. 394, doi. 10.1093/neuonc/now189
    By:
    • Nguyen, HuyTram N.;
    • Lie, Amy;
    • Li, Tie;
    • Chowdhury, Reshmi;
    • Liu, Fei;
    • Ozer, Byram;
    • Wei, Bowen;
    • Green, Richard M.;
    • Ellingson, Benjamin M.;
    • Wang, He-jing;
    • Elashoff, Robert;
    • Liau, Linda M.;
    • Yong, William H.;
    • Nghiemphu, Phioanh L.;
    • Cloughesy, Timothy;
    • Lai, Albert
    Publication type:
    Article
    8

    Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.

    Published in:
    Neuro-Oncology, 2014, v. 16, n. 6, p. 815, doi. 10.1093/neuonc/nou028
    By:
    • Piccioni, David E.;
    • Selfridge, Julia;
    • Mody, Reema R.;
    • Chowdhury, Reshmi;
    • Li, Sichen;
    • Lalezari, Shadi;
    • Wawrzynski, James;
    • Quan, Jennifer;
    • Zurayk, Mira;
    • Chou, Arthur P.;
    • Sanchez, Desiree E.;
    • Liau, Linda M.;
    • Ellingson, Benjamin M.;
    • Pope, Whitney B.;
    • Nghiemphu, Phioanh L.;
    • Green, Richard M.;
    • Wang, He-jing;
    • Yong, William H.;
    • Elashoff, Robert;
    • Cloughesy, Timothy F.
    Publication type:
    Article
    9
    10
    11
    12

    Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 19, p. 1458, doi. 10.1093/jnci/djs357
    By:
    • Chou, Arthur P.;
    • Chowdhury, Reshmi;
    • Li, Sichen;
    • Chen, Weidong;
    • Kim, Andrew J.;
    • Piccioni, David E.;
    • Selfridge, Julia M.;
    • Mody, Reema R.;
    • Chang, Stephen;
    • Lalezari, Shadi;
    • Lin, Jeffrey;
    • Sanchez, Desiree E.;
    • Wilson, Ryan W.;
    • Garrett, Matthew C.;
    • Harry, Bret;
    • Mottahedeh, Jack;
    • Nghiemphu, Phioanh L.;
    • Kornblum, Harley I.;
    • Mischel, Paul S.;
    • Prins, Robert M.
    Publication type:
    Article
    13